MXPA06002778A - Combinacion de inhibidores de recaptacion de serotonina e inhibidores de recaptacion de norepinefrina. - Google Patents

Combinacion de inhibidores de recaptacion de serotonina e inhibidores de recaptacion de norepinefrina.

Info

Publication number
MXPA06002778A
MXPA06002778A MXPA06002778A MXPA06002778A MXPA06002778A MX PA06002778 A MXPA06002778 A MX PA06002778A MX PA06002778 A MXPA06002778 A MX PA06002778A MX PA06002778 A MXPA06002778 A MX PA06002778A MX PA06002778 A MXPA06002778 A MX PA06002778A
Authority
MX
Mexico
Prior art keywords
reuptake inhibitors
combination
norepinephrine
serotonin
norepinephrine reuptake
Prior art date
Application number
MXPA06002778A
Other languages
English (en)
Inventor
Erik Ho Fong Wong
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/769,018 external-priority patent/US20050014848A1/en
Priority claimed from US10/860,721 external-priority patent/US20050009927A1/en
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MXPA06002778A publication Critical patent/MXPA06002778A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta invencion esta dirigida, en una modalidad, a composiciones farmaceuticas y metodos para tratar depresion en un mamifero, a un mamifero en necesidad de dicho tratamiento se le administran: (i) por lo menos un inhibidor de recaptacion de serotonina o una sal farmaceuticamente aceptable del mismo, y (ii) por lo menos un inhibidor de recaptacion de norepinefrina o una sal farmaceuticamente aceptable del mismo, en donde el inhibidor de recaptacion de norepinefrina se selecciona del grupo formado por la estructura II, la estructura III y la estructura IV, segun se define en la presente.
MXPA06002778A 2003-09-09 2004-09-02 Combinacion de inhibidores de recaptacion de serotonina e inhibidores de recaptacion de norepinefrina. MXPA06002778A (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US50127503P 2003-09-09 2003-09-09
US53889804P 2004-01-23 2004-01-23
US54069604P 2004-01-30 2004-01-30
US10/769,018 US20050014848A1 (en) 2002-01-23 2004-01-30 Combination of serotonin reuptake inhibitors and norephinephrine reuptake inhibitors
US10/860,721 US20050009927A1 (en) 2002-01-23 2004-06-03 Combination of serotonin reuptake inhibitors and norepinephrine reuptake inhibitors
PCT/IB2004/002864 WO2005023265A1 (en) 2003-09-09 2004-09-02 Combination of serotonin reuptake inhibitors and norepinephrine reuptake inhibitors

Publications (1)

Publication Number Publication Date
MXPA06002778A true MXPA06002778A (es) 2006-06-14

Family

ID=34280166

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06002778A MXPA06002778A (es) 2003-09-09 2004-09-02 Combinacion de inhibidores de recaptacion de serotonina e inhibidores de recaptacion de norepinefrina.

Country Status (7)

Country Link
EP (1) EP1667686A1 (es)
BR (1) BRPI0413726A (es)
CA (1) CA2542339A1 (es)
MX (1) MXPA06002778A (es)
NL (1) NL1026989C2 (es)
TW (1) TW200526197A (es)
WO (1) WO2005023265A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR042806A1 (es) 2002-12-27 2005-07-06 Otsuka Pharma Co Ltd Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo
CA2511619C (en) 2002-12-27 2011-07-12 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
WO2006000903A2 (en) * 2004-06-09 2006-01-05 Pfizer Limited Use of reboxetine for the treatment of pain
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2483093A1 (en) * 2002-04-24 2003-11-06 Cypress Bioscience, Inc. Use of milnacipran or a pharmaceutically acceptable salt thereof for treating chronic low back pain

Also Published As

Publication number Publication date
EP1667686A1 (en) 2006-06-14
WO2005023265A1 (en) 2005-03-17
BRPI0413726A (pt) 2006-11-07
TW200526197A (en) 2005-08-16
NL1026989A1 (nl) 2005-03-10
CA2542339A1 (en) 2005-03-17
NL1026989C2 (nl) 2006-01-10

Similar Documents

Publication Publication Date Title
DK1933833T3 (da) Terapi til behandling af overaktiv blære
NO20055863L (no) W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer
RS20050392A (en) Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor
DE60114994D1 (de) Blutplättchen-adp-rezeptor-inhibitoren
EA200900613A1 (ru) Спирокетоновые ингибиторы ацетил-коа-карбоксилаз
WO2009155121A3 (en) Inhibitors of pi3 kinase
NO20025601D0 (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
MY140840A (en) Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
UA92000C2 (en) 1-benzylindole-2-carboxamide derivatives
NZ598778A (en) Combination therapy with SGLT-2 inhibitors and their pharmaceutical compositions
TW200639159A (en) Treatment of pain
ATE548034T1 (de) Pharmazeutische zusammensetzungen mit droxidopa
WO2007024843A3 (en) Pyrimidinyl-pyrazole inhibitors of aurora kinases
ZA200806778B (en) N-Hydroxyacrylamide compounds
EA200702282A1 (ru) Комбинация феррохина и производного артемизинина для лечения малярии
WO2007056142A3 (en) Methods of preventing the serotonin syndrome and compositions for use therefor
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
DK1370260T3 (da) Azoler, som malonyl-coa-decarboxylaseinhibitorer anvendelige som mataboliske modulatorer
IL179206A0 (en) Pyrrolylpyrimidine derivatives and pharmaceutical compositions containing the same
TW200509949A (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
DK1784173T3 (da) Farmaceutisk sammensætning til forebyggelse og behandling af metaboliske knoglesygdomme indeholdende alpha-arylmethoxyacrylatderivater
MX2009005798A (es) Recuperacion de apoplejia.
WO2006023187A3 (en) Cycloalkylamine derivatives as nk-1 /ssri antagonists
MXPA06002778A (es) Combinacion de inhibidores de recaptacion de serotonina e inhibidores de recaptacion de norepinefrina.
EA200600998A1 (ru) Фармацевтическая композиция, содержащая цинк-гиалуронановый комплекс, предназначенная для лечения рассеянного склероза

Legal Events

Date Code Title Description
FA Abandonment or withdrawal